Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional Results available

A Study of Navenibart (STAR-0215) in Participants With Hereditary Angioedema

ClinicalTrials.gov ID: NCT05695248

Public ClinicalTrials.gov record NCT05695248. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 2:14 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1b/2 Single and Multiple Dose Study to Assess the Safety, Tolerability, Clinical Activity, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of STAR-0215 in Participants With Hereditary Angioedema (The ALPHA-STAR Trial)

Study identification

NCT ID
NCT05695248
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Astria Therapeutics, Inc.
Industry
Enrollment
29 participants

Conditions and interventions

Interventions

  • Navenibart Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 20, 2023
Primary completion
Mar 12, 2025
Completion
Mar 12, 2025
Last update posted
May 7, 2026

2023 – 2025

United States locations

U.S. sites
13
U.S. states
10
U.S. cities
13
Facility City State ZIP Site status
Allervie Clinical Research Birmingham Alabama 35209
Medical Research of Arizona a Division of Allergy, Asthma & Immunology Associates, LTD. Scottsdale Arizona 85251
Allergy & Asthma Clinic of Northwest Arkansas Bentonville Arkansas 72712
Acuro Research, Inc. Little Rock Arkansas 72205
UC San Diego US HAEA Angioedema Center San Diego California 92122
Raffi Tachdjian MD, Inc Santa Monica California 90404
Allergy & Asthma Clinical Research Walnut Creek California 94598
Institute for Asthma and Allergy, PC Chevy Chase Maryland 20815
Massachusetts General Hospital Boston Massachusetts 02114
Washington University School of Medicine St Louis Missouri 63110
Optimed Research Columbus Ohio 43235
Penn State Health Milton S. Hershey Medical Center Hershey Pennsylvania 17033
AARA Research Center Dallas Texas 75231

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05695248, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 7, 2026 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05695248 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →